---
title: ICON plc vs Parexel
slug_a: iconplc
slug_b: parexel
site: cro
review_signal_gate: closed
canonical_path: /compare/iconplc/parexel
generated_by: BioBM Editorial AI
---

# ICON plc vs Parexel

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

ICON plc (iconplc) is listed for cro. ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.

Services: 29. Modalities: 6. Indications: 9. Locations: 52. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (52).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Parexel (parexel) is listed for cro. Parexel is a comprehensive CRO offering end-to-end biopharmaceutical development services spanning portfolio optimization, early development, integrated clinical development, regulatory approval, and lifecycle value substantiation.

Services: 17. Modalities: 3. Indications: 12. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (17).

Review summary: Review summary withheld until site-level review gate opens.